Alivus Life Sciences Limited files a merger or restructuring document
In short
Alivus Life Sciences Limited has filed papers covering a merger, acquisition or internal restructuring. The scheme in the filing is what actually defines the deal.
What the reporting says
Alivus Life Sciences Limited filed this with NSE on 18 Aug 2026 at 18:16 IST, under the exchange's own "M&A / restructuring" classification. The exchange's record of the filing reads: "Alivus Life Sciences Limited has informed the Exchange regarding Acquisition (including agreement to acquire)…"
Why it matters
A merger, acquisition or corporate restructuring is in motion — the scheme details in the filing matter more than the headline. This brief was written from the filing itself: at the time of writing, no publisher in our feed had covered it.